This satellite symposium took place on 9th June 2016, as a part of the 21st Congress of the European Hematology Association (EHA) 2016 in Copenhagen, Denmark
Chairperson: Gérard Socié1
Speakers: Austin Kulasekararaj,2 Gérard Socié,1 Alexander Röth3
1. Service d’Hématologie-Greffe de Moelle, Hôpital Saint-Louis, Paris, France
2. Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust and King’s College London School of Medicine, London, UK
3. Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany
Disclosure: Prof Socié is a consultant for Alexion Pharmaceuticals. Dr Kulasekararaj has received funding and speaker’s honoraria from Alexion, Celgene, Novartis, and Amgen. Dr Röth has received honoraria, has membership of an entity’s board of directors and advisory committees, and has research funding from Alexion Pharmaceuticals.
Acknowledgements: Writing assistance was provided by Dr Joan Thomas of ApotheCom.
Support: The symposium and publication of this article was sponsored by Alexion Pharmaceuticals Inc. Authors received honoraria for preparation and delivery of their presentations. The views and opinions expressed are those of the authors and not necessarily Alexion Pharmaceuticals Inc.
Citation: EMJ Hematol. 2016;4:47-54
Several rare haematological diseases are linked to bone marrow failure (BMF). This symposium provided the latest scientific insights into the different pathophysiological mechanisms and clinical advances in the management of these conditions, with a specific focus on the clinical management of patients with paroxysmal nocturnal haemoglobinuria (PNH) in the context of aplastic anaemia (AA), and the pathophysiology, consequences, and identification of PNH in the context of BMF.
Prof Gérard Socié chaired the symposium and overviewed BMF. Dr Austin Kulasekararaj gave a presentation on new paradigms in BMF, followed by Prof Gérard Socié, who reviewed the diagnosis and management of AA. Dr Alexander Röth then discussed the diagnosis and management of PNH in the context of BMF. The symposium was concluded by a short question and answer session.